MustGrow Biologics Signs Non-Binding Term-Sheet for Acquisition of NexusBioAg

Share This Article

MustGrow Biologics Corp., a frontrunner in the biological and regenerative agriculture space, has announced the signing of a non-binding term sheet for the proposed acquisition of NexusBioAg, a division of Univar Solutions Canada Ltd. This monumental step is set to transform MustGrow into a fully integrated provider of biological solutions, further solidifying its position as a leader in the sustainable agriculture sector.

The Vision Behind the Acquisition

This acquisition aligns with MustGrow’s mission to innovate and deliver cutting-edge solutions for farmers, enabling them to adopt sustainable and regenerative farming practices. By acquiring NexusBioAg, MustGrow aims to expand its product offerings, enhance market reach, and establish a robust sales, marketing, and distribution network in Canada.

NexusBioAg, known for its extensive experience in biological and regenerative agriculture, will bring its well-established relationships with growers, channel partners, and influencers to MustGrow’s operations. This move is anticipated to create synergies, offering significant growth opportunities and reducing distribution costs for MustGrow’s proprietary products.

What’s Next? Key Highlights of the Deal

The acquisition is subject to several conditions, including:

Completion of Due Diligence: Both parties will engage in a comprehensive review process to finalize the details.

Definitive Agreements: A definitive asset purchase agreement is under negotiation.

Approvals: The transaction requires the green light from the TSX Venture Exchange and MustGrow’s Board of Directors.

The purchase consideration is expected to include deferred cash payments and contingent payments in 2025 and 2026. The closing of the transaction is targeted for the end of the year.

A New Era for MustGrow: The Integration Plan

Upon completion of the acquisition, MustGrow will integrate NexusBioAg’s product line with its existing offerings, creating a comprehensive portfolio. This includes:
Sales and Marketing Synergies: NexusBioAg’s experienced team will enhance MustGrow’s commercialization efforts for biological and regenerative products.

Product Expansion: New third-party product lines are anticipated in 2025, along with the launch of MustGrow’s proprietary TerraMG™.

Industry Growth: Leveraging NexusBioAg’s proven commercialization model, MustGrow aims to accelerate innovation and drive market success.

Corey Giasson, President & CEO of MustGrow, expressed his enthusiasm:
“This synergistic acquisition would solidify MustGrow’s position as a fully integrated biological and regenerative agriculture company, with an established in-licensed third-party product line, while laying the foundation for the commercialization of MustGrow’s own innovative products.”

Engaging the Community: Webinar Details

To share insights about this transformative acquisition, MustGrow will host a live webinar with its CEO, Corey Giasson, and COO, Colin Bletsky. This interactive event will provide an opportunity for stakeholders to ask questions and learn more about MustGrow’s strategic vision.

For those unable to attend, an archived version of the webcast will be available.

A Promising Future in Sustainable Agriculture

As MustGrow Biologics moves forward with this strategic acquisition, it not only strengthens its foothold in the Canadian market but also sets the stage for future expansion into the U.S. The integration of NexusBioAg’s expertise and MustGrow’s innovation underscores the company’s commitment to delivering sustainable, technology-driven solutions to farmers globally.

Source- Must grow

Leave a Reply

Your email address will not be published. Required fields are marked *